Cargando…
Molecular classifications of gastric cancers: Novel insights and possible future applications
Despite some notable advances in the systemic management of gastric cancer (GC), the prognosis of patients with advanced disease remains overall poor and their chance of cure is anecdotic. In a molecularly selected population, a median overall survival of 13.8 mo has been reached with the use of hum...
Autores principales: | Garattini, Silvio Ken, Basile, Debora, Cattaneo, Monica, Fanotto, Valentina, Ongaro, Elena, Bonotto, Marta, Negri, Francesca V, Berenato, Rosa, Ermacora, Paola, Cardellino, Giovanni Gerardo, Giovannoni, Mariella, Pella, Nicoletta, Scartozzi, Mario, Antonuzzo, Lorenzo, Silvestris, Nicola, Fasola, Gianpiero, Aprile, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434387/ https://www.ncbi.nlm.nih.gov/pubmed/28567184 http://dx.doi.org/10.4251/wjgo.v9.i5.194 |
Ejemplares similares
-
The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients
por: Basile, Debora, et al.
Publicado: (2019) -
Drug Holidays and Overall Survival of Patients with Metastatic Colorectal Cancer
por: Garattini, Silvio Ken, et al.
Publicado: (2021) -
The SAFFO Study: Sex-Related Prognostic Role and Cut-Off Definition of Monocyte-to-Lymphocyte Ratio (MLR) in Metastatic Colorectal Cancer
por: Lisanti, Camilla, et al.
Publicado: (2022) -
HER-2 inhibition in gastric and colorectal cancers: tangible achievements, novel acquisitions and future perspectives
por: Fanotto, Valentina, et al.
Publicado: (2016) -
Radium-223 and metastatic castration-resistant prostate cancer: All that glitters is not gold
por: Aprile, Carlo, et al.
Publicado: (2016)